SHANGHAI FOSUN PHARMACEUTICAL (GROUP) financial statements, including revenue, expenses, profit, and loss

The total revenue of 600196 for the last quarter is 10.38 B CNY, and it's 1.42% higher compared to the previous quarter. The net income of Q3 24 is 785.84 M CNY.